Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03796689 · ClinicalTrials.gov registry record · NA
The PCORnet Blood Pressure Home Monitoring Study
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 2,238
- Enrollment target
NCT03796689: Completed NA study, sponsored by University of California, San Francisco.
NCT03796689 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 2,238 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03796689, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,238 participants
- Enrollment target
Study Summary
The PCORnet Blood Pressure Home Monitoring (BP HOME) Study is a patient-level randomized controlled trial that will compare the effectiveness of home blood pressure monitoring (HPBM) with versus without a linked Smartphone application ("app") for helping patients with uncontrolled hypertension achieve a reduction in systolic blood pressure. The trial will be conducted within the National Patient-Centered Clinical Research Network (PCORnet), which supports a research network that enables distributed querying of EHR data in a common data model. It will also use the Eureka Research Platform, an online research platform hosted by UCSF that supports eConsent, online surveys, and data collection from devices such as HBPMs. Data from these two data sources will be used together to accomplish the study aims. Given that HBPM is the guideline-recommended standard of care (without specification of Smartphone linkage), the HPBM devices and the app are all commercially available and currently in use, and that clinicians, with input from patients, will maintain full control of how BP is clinically managed, we believe participation in the project poses minimal risk to participants.
Primary Outcome
Change is defined by the absolute difference between the SBP measured at the most recent outpatient clinical encounter at the time of enrollment, and the SBP measured at the most recent outpatient clinical encounter 6 months after enrollment. If more than 1 measurement is recorded during a single clinical encounter, the lower/lowest will be used.
Interventions
- DEVICE Smartphone-linked HBPM and associated app
- DEVICE Standard HBPM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,238 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2021-10-23 |
| Phase | NA |
What the finished NCT03796689 record still lists
NCT03796689 is an interventional study that assigns participants to a tested intervention. Its 2,238 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% higher).
The record links to 0 conditions, and to 2 interventions - of which Smartphone-linked HBPM and associated app is the first listed.
NCT03796689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03796689 about?
NCT03796689 is a clinical study titled "The PCORnet Blood Pressure Home Monitoring Study". The PCORnet Blood Pressure Home Monitoring (BP HOME) Study is a patient-level randomized controlled trial that will compare the effectiveness of home blood pressure monitoring (HPBM) with versus without a linked Smartphone application ("app") for helping patients with uncontrolled hypertension achie...
What is the current status of trial NCT03796689?
This trial is currently completed. It is a NA study. The enrollment target is 2,238 participants. The study started on 2019-08-15. Estimated completion is 2021-10-23.
What interventions are being tested in trial NCT03796689?
The interventions under investigation include: Smartphone-linked HBPM and associated app (DEVICE), Standard HBPM (DEVICE).
Who is sponsoring clinical trial NCT03796689?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03796689's enrollment target sits among peer trials
2,238 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI